Lenvatinib and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Lenvatinib and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib-Tilia Fe
- Lenvatinib-Tiludronate
- Lenvatinib-Timentin
- Lenvatinib-Timentin Add-Vantage
- Lenvatinib-Timentin Injection
- Lenvatinib-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Lenvatinib Mesylate
- Tildrakizumab-asmn Subcutaneous-Lenvima
- Tildrakizumab-asmn Subcutaneous-Lenvima (14 MG Daily Dose)
- Tildrakizumab-asmn Subcutaneous-Lenvima (18 MG Daily Dose)
- Tildrakizumab-asmn Subcutaneous-Lenvima (20 MG Daily Dose)
- Tildrakizumab-asmn Subcutaneous-Lenvima (24 MG Daily Dose)